Henry Schein (HSIC) – Research Analysts’ Recent Ratings Updates

Henry Schein (NASDAQ: HSIC) recently received a number of ratings updates from brokerages and research firms:

• 3/7/2023 – Henry Schein had its price target raised by analysts at UBS Group AG from $75.00 to $82.00. They now have a “neutral” rating on the stock.
• 2/28/2023 – Henry Schein had its price target lowered by analysts at Credit Suisse Group AG from $99.00 to $97.00. They now have an “outperform” rating on the stock.
• 2/21/2023 – Henry Schein had its price target lowered by analysts at Morgan Stanley from $70.00 to $69.00. They now have an “underweight” rating on the stock.
• 2/17/2023 – Henry Schein had its price target lowered by analysts at Barrington Research from $99.00 to $92.00. They now have an “outperform” rating on the stock.
• 2/6/2023 – Henry Schein had its price target raised by analysts at Piper Sandler from $85.00 to $97.00. They now have an “overweight” rating on the stock.
• 1/19/2023 – Henry Schein was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 1/10/2023 – Henry Schein was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.

Henry Schein Stock Up 0.2 %

Shares of NASDAQ HSIC opened at $77.81 on Thursday. The stock has a 50 day moving average price of $82.40 and a 200 day moving average price of $77.14. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.91 and a current ratio of 1.79. The firm has a market capitalization of $10.21 billion, a price-to-earnings ratio of 20.00, a PEG ratio of 1.81 and a beta of 0.80. Henry Schein, Inc. has a 52-week low of $64.75 and a 52-week high of $92.68.

Henry Schein (NASDAQ:HSIC – Get Rating) last issued its quarterly earnings data on Thursday, February 16th. The company reported $1.35 EPS for the quarter, beating the consensus estimate of $1.21 by $0.14. Henry Schein had a return on equity of 15.79% and a net margin of 4.25%. The firm had revenue of $3.37 billion during the quarter, compared to analyst estimates of $3.37 billion. During the same quarter in the prior year, the business posted $1.07 EPS. The business’s revenue for the quarter was up 1.2% compared to the same quarter last year. Sell-side analysts expect that Henry Schein, Inc. will post 5.34 earnings per share for the current year.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 6,840 shares of Henry Schein stock in a transaction that occurred on Wednesday, December 21st. The shares were sold at an average price of $80.71, for a total value of $552,056.40. Following the completion of the sale, the chief executive officer now owns 55,412 shares in the company, valued at approximately $4,472,302.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,840 shares of the business’s stock in a transaction that occurred on Wednesday, December 21st. The stock was sold at an average price of $80.71, for a total value of $552,056.40. Following the completion of the sale, the chief executive officer now owns 55,412 shares in the company, valued at $4,472,302.52. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Stanley M. Bergman sold 54,216 shares of the business’s stock in a transaction that occurred on Monday, December 12th. The shares were sold at an average price of $81.16, for a total value of $4,400,170.56. Following the completion of the sale, the chief executive officer now owns 488,126 shares of the company’s stock, valued at approximately $39,616,306.16. The disclosure for this sale can be found here. Insiders sold 82,802 shares of company stock worth $6,694,575 in the last 90 days. Insiders own 1.00% of the company’s stock.

Institutional Trading of Henry Schein

Several institutional investors and hedge funds have recently made changes to their positions in the stock. Voya Investment Management LLC lifted its position in Henry Schein by 0.8% during the fourth quarter. Voya Investment Management LLC now owns 53,074 shares of the company’s stock worth $4,239,000 after buying an additional 447 shares during the period. Natixis grew its stake in Henry Schein by 81.6% during the 4th quarter. Natixis now owns 17,159 shares of the company’s stock valued at $1,370,000 after purchasing an additional 7,709 shares in the last quarter. Truist Financial Corp lifted its holdings in Henry Schein by 38.8% during the 4th quarter. Truist Financial Corp now owns 16,300 shares of the company’s stock worth $1,302,000 after buying an additional 4,555 shares during the last quarter. Linden Thomas Advisory Services LLC bought a new position in Henry Schein during the 4th quarter worth approximately $340,000. Finally, GHP Investment Advisors Inc. lifted its holdings in Henry Schein by 4.8% during the 4th quarter. GHP Investment Advisors Inc. now owns 47,776 shares of the company’s stock worth $3,816,000 after buying an additional 2,175 shares during the last quarter. 95.45% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein, Inc engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution, and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgicals, diagnostic tests, infection-control products and vitamins.